Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - OTHER CURRENT LIABILITIES
Other Current Liabilities ESPR - Esperion Therapeutics, Inc.
62.7 M
LAST VALUE
29.46%
2 YEAR CAGR
26.46%
5 YEAR CAGR
42.04%
10 YEAR CAGR